salicylic acid and n-(4-chloro-2-fluorophenyl)-2-hydroxybenzamide

salicylic acid has been researched along with n-(4-chloro-2-fluorophenyl)-2-hydroxybenzamide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmed Ali, AA; Chang, DM; Chen, CL; Chen, TC; Huang, HS; Lee, CC; Liu, FL; Sytwu, HK1
Chiang, ML; Ho, LJ; Huang, HS; Lai, JH; Lin, CS; Liou, JT; Yang, SP1

Other Studies

2 other study(ies) available for salicylic acid and n-(4-chloro-2-fluorophenyl)-2-hydroxybenzamide

ArticleYear
Modified salicylanilide and 3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-dione derivatives as novel inhibitors of osteoclast differentiation and bone resorption.
    Journal of medicinal chemistry, 2014, Oct-09, Volume: 57, Issue:19

    Topics: Animals; Bone Resorption; Cell Differentiation; Cells, Cultured; Mice; Osteoclasts; Oxazines; RANK Ligand; Salicylanilides; Structure-Activity Relationship

2014
A salicylate-based small molecule HS-Cm exhibits immunomodulatory effects and inhibits dipeptidyl peptidase-IV activity in human T cells.
    European journal of pharmacology, 2014, Mar-05, Volume: 726

    Topics: Benzamides; Biomarkers; Cytokines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; DNA; Down-Regulation; Enzyme Activation; Humans; Immunologic Factors; JNK Mitogen-Activated Protein Kinases; Lymphocyte Activation; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Salicylic Acid; T-Lymphocytes; Transcription Factor AP-1

2014